Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

How to Win Cancer Limbo Through Celebration

December 19th 2017, 9:26pm

Article

Should I be planning big, celebratory trips or my funeral? My fears may not be rational, but they're real.

Fallopian Tube Removal May Help Prevent Most Common Ovarian Cancer

December 19th 2017, 6:55pm

Article

Recent findings that the most common kind of ovarian cancer may start in the fallopian tubes could have implications for the prevention, diagnosis and treatment of the disease subtype.

Looking Ahead: Ovarian Cancer Hopes for 2018

December 19th 2017, 2:24am

Video

Oliver Dorigo, M.D., Ph.D., Associate Professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, talks about the direction of research in the ovarian cancer field going into 2018 and beyond.

Self-Image and Cancer: Seeing the New, Better You

December 14th 2017, 1:55am

Article

No matter how cancer makes you look, you’re still you—a better you.

Striving for Better Ovarian Cancer Screening Methods

December 12th 2017, 1:44am

Video

Oliver Dorigo, M.D., Ph.D., associate professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, discusses the lack of effective screening methods for ovarian cancer.

Ovarian Cancer Developments in 2017

December 7th 2017, 12:01am

Video

Oliver Dorigo, M.D., Ph.D., Associate Professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, discusses recent exciting developments in the ovarian cancer field.

Maintenance Rubraca Granted Priority Review for Ovarian Cancer

December 6th 2017, 10:25pm

Article

A supplemental new drug application (sNDA) for Rubraca (rucaparib), a PARP inhibitor, has been granted a priority review by the Food and Drug Administration.

Longer Time Between Pre- And Postoperative Chemo Worsens Survival in Ovarian Cancer

December 5th 2017, 9:27pm

Article

Longer time in between pre- and postoperative chemotherapy may be associated with significantly worse survival outcomes in women with ovarian cancer.

PARP Inhibitors Continue to Show Promise in Ovarian Cancer

November 29th 2017, 7:35pm

Article

As PARP inhibitors continue to improve outcomes in patients with ovarian cancer, they may one day be moved into the frontline treatment setting, said Susana M. Campos, M.D., a gynecologic oncologist at Dana-Farber Cancer Institute and an assistant professor at Harvard Medical School.

Stay Informed and Healthy During Cancer

November 28th 2017, 8:32pm

Video

When facing ovarian cancer, it is critical to stay healthy and well-informed, says Anya Khomenko.